Recent News

• 10.01.2025 - Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio
• 10.01.2025 - Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio
• 09.23.2025 - Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System
• 09.23.2025 - Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System
• 09.16.2025 - Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
• 09.16.2025 - Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds
• 09.15.2025 - Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds
• 09.15.2025 - Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds
• 09.09.2025 - REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference
• 09.09.2025 - REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference

Recent Filings

• 10.01.2025 - EX-99.1 EX-99.1
• 10.01.2025 - 8-K Current report
• 09.30.2025 - D Notice of Exempt Offering of Securities
• 09.23.2025 - 8-K Current report
• 09.23.2025 - EX-99.1 EX-99.1
• 09.19.2025 - 8-K Current report
• 09.16.2025 - 8-K Current report
• 09.16.2025 - EX-99.1 EX-99.1
• 09.09.2025 - 8-K Current report
• 09.09.2025 - EX-99.1 EX-99.1